Wurm, Raphael <br/><br/>
Cardiovascular safety of metformin and sulfonylureas in patients with different cardiac risk profiles.  [electronic resource] 

 -  Heart (British Cardiac Society)  10 2016 
 - 1544-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study 
<br/><br/><label>ISSN: </label>1468-201X 
<br/><br/><label>Standard No.: </label>10.1136/heartjnl-2015-308711  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Austria<br/>Biomarkers--blood<br/>Cardiovascular Diseases--blood<br/>Chi-Square Distribution<br/>Diabetes Mellitus, Type 2--blood<br/>Female<br/>Humans<br/>Hypoglycemic Agents--adverse effects<br/>Male<br/>Metformin--adverse effects<br/>Middle Aged<br/>Natriuretic Peptide, Brain--blood<br/>Peptide Fragments--blood<br/>Proportional Hazards Models<br/>Prospective Studies<br/>Protective Factors<br/>Risk Assessment<br/>Risk Factors<br/>Sulfonylurea Compounds--adverse effects<br/>Time Factors<br/>Treatment Outcome